Manhattan Associates Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Manhattan Associates Inc trades at $206.18 (market cap $11.79B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Manhattan Associates Inc is far larger — about 3× Relay Therapeutics Inc. Common Stock's market cap, and Manhattan Associates Inc is more actively traded (393,599 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MANH | RLAY | |
|---|---|---|
Market Cap | $11.79B | $3.94B |
Volume | 393,599 | 3,432,928 |
Sector | Technology | Health |
52-Week High | $223.76 | $20.75 |
52-Week Low | $120.88 | $6.03 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $11.66B | $3.06B |
Signals from Pluang's Aura AI — not financial advice
MANH trades at $202.11, down 0.36% on the day, with a bearish technical signal and key support at $201. The company shows strong profitability with a net income margin of 18.67% and has beaten earnings estimates for the last three quarters. Recent news includes a law firm investigation into fiduciary duties and a product launch of Editions for its supply chain solutions.
The outlook is mixed: strong fundamentals and analyst buy ratings support upside to the $210.50 consensus target, but technical weakness and the ongoing legal investigation pose near-term risks. Earnings growth remains the key catalyst for further price appreciation.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →